1:42 PM
 | 
Jun 28, 2017
 |  BC Extra  |  Financial News

Novo Seeds invests €2.7M in Antag

Metabolic start-up Antag Therapeutics ApS (Copenhagen, Denmark) said it has received a €2.7 million ($3 million) investment from Novo Seeds, the early stage investment arm of Novo Holdings A/S (Hellerup, Denmark).

Antag is developing peptide...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >